Global In Vivo Toxicology Market Overview: Trends Shaping Growth to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The In Vivo Toxicology Industry By The Forecast Year 2029?

The in-vivo toxicology market has experienced significant growth in recent years. It is anticipated to expand from $5.24 billion in 2024 to $5.61 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.1%. This historical growth can be attributed to the increasing demand for GLP-compliant studies, the broadening of reach regulations, the rise in biologics and biosimilars requiring safety assessments, greater investment in oncology drug development, and the expansion of gene and cell therapy pipelines.

The in-vivo toxicology market is projected to experience robust expansion over the coming years, reaching $7.31 billion by 2029, with a compound annual growth rate (CAGR) of 6.8%. This anticipated growth during the forecast period is fueled by several factors, including an increase in global drug development initiatives, a heightened demand for personalized medicine, a greater number of clinical trials, pharmaceutical companies’ increased outsourcing of toxicology testing, and heightened consumer safety concerns regarding food and personal care items. Key trends expected during this period encompass the creation of sophisticated animal models, the incorporation of imaging technologies into in vivo research, the rise of automated data collection mechanisms, the application of AI and ML for analyzing toxicology data, and advancements in animal telemetry and biomarker identification.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25791&type=smp

What Are The Top Growth Drivers Impacting The In Vivo Toxicology Market Outlook?

The escalating volume of drug discoveries is anticipated to fuel the expansion of the in vivo toxicology market moving forward. Drug discovery is defined as the scientific process of identifying and designing new compounds that can act as treatments or preventatives for various conditions. Advancements in biotechnology have significantly propelled this process by enhancing our comprehension of disease mechanisms and enabling the development of more targeted therapies. In this context, in vivo toxicology is indispensable, providing the means to assess the safety, tolerability, and potential adverse reactions of investigational compounds within whole organisms. It is instrumental in identifying dose-limiting toxicities and informing strategies for formulation and dosing before compounds advance to clinical development. As an illustration, in May 2025, a report from the Government of Canada, a Canada-based constitutional body, revealed that the worldwide count of medicines in clinical development reached 10,134 in March 2025, marking a 20% growth compared to September 2021. Thus, the growing number of drug discoveries is a primary driver for the in vivo toxicology market’s growth.

Which Key Segments Fueling The In Vivo Toxicology Market?

The in vivo toxicology market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Testing Types: Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, Acute Toxicity Testing

3) By Methodology: In Vivo Animal Models, Genetically Modified Organisms, Non-Human Primate Studies, Rodent Models, Larger Mammals

4) By Application: Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental And Reproductive Toxicity (DART), Other Applications

5) By End-User: Pharmaceutical Companies, Biosimilars Manufacturers, Contract Research Organizations (CROs), Academic And Research Institutions, Biotechnology Firms

Subsegments:

1) By Consumables: Animal Models, Reagents And Kits, Assay Kits, Toxicology Testing Media, Antibodies, Biochemicals, Buffers And Solutions, Disposable Labware, Animal Feed, Diluents

2) By Instruments: Imaging Systems, Flow Cytometers, PCR Machines, Spectrophotometers, Microscopes, Analyzers, Centrifuges, Incubators, Animal Monitoring Systems, Automated Liquid Handling Systems

What Trends Are Expected To Drive The In Vivo Toxicology Market?

Leading firms within the in vivo toxicology market are concentrating on creating sophisticated solutions, including secure cloud-based real-time data platforms, aiming to optimize study management and accelerate decision-making processes. These secure cloud-based real-time data platforms facilitate remote and secure access for researchers and clients to toxicology study data, key milestones, planning utilities, and documentation, thereby fostering improved collaboration and transparency. An example of this is the launch of Apollo in March 2023 by Charles River Laboratories International Inc., a US-based contract research organization. Apollo is a secure cloud-based platform specifically designed to offer real-time access to toxicology study data. This particular platform is a secure, cloud-based system intended to assist in vivo general toxicology studies, providing instruments for data visualization, planning, and tracking significant milestones. By furnishing real-time access to crucial study data, it facilitates faster and more well-informed decision-making. Furthermore, the platform aids in streamlining both project planning and budget estimations across the entire drug development lifecycle. Through the digitization of toxicology workflows, Apollo significantly boosts precision, efficiency, and collaborative efforts within in vivo research.

Which Major Industry Participants Are Leading The In Vivo Toxicology Market Growth?

Major companies operating in the in vivo toxicology market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Sigma-Aldrich Co. LLC, Eurofins Scientific SE, SGS Société Générale de Surveillance SA, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Jubilant Life Sciences Limited, Evotec SE, The Jackson Laboratory, Inotiv Inc., SRI International, MatTek Corporation, Transcure Bioservices Pvt. Ltd., Altogen Labs.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/in-vivo-toxicology-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The In Vivo Toxicology Market?

North America was the largest region in the in-vivo toxicology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo toxicology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The In Vivo Toxicology Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25791&type=smp

Browse Through More Reports Similar to the Global In Vivo Toxicology Market 2025, By The Business Research Company

In Vitro Toxicology Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Adme Toxicology Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Genetic Toxicology Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795